IL22 and colonic neoplasm: Moreover, in a colitis-associated colon cancer model, IL-22BP-deficient mice showed accelerated tumor development and an increase in quantity and size of tumors compared to wild type control mice, suggesting an important role for IL-22 in colitis-associated CRC [96].